Alcon completes acquisition of Israeli co Belkin Vision

Daria Lemann-Blumenthal credit: Tim Kerr
Daria Lemann-Blumenthal credit: Tim Kerr

Alcon will make an immediate payment of $81 million and a further $385 million in milestone payments, according to the product's success on the market.

The share price of Israeli ophthalmology investment firm BioLight Life Sciences (TASE: BOLT) rose 2% today after Israeli glaucoma treatment company Belkin Vision, in which it holds a 4% stake, announced that it had completed its sale to Swiss-American ophthalmology company Alcon (SWX: ALC).

BioLight reported on the deal in May and since then its share price has risen 40% and it currently has a market cap of NIS 22 million.

Alcon is acquiring Belkin Vision, which has developed laser-based technology for glaucoma treatment for up to $466 million, including an immediate payment of $81 million and a further $385 million in milestone payments according to the product's success on the market.

BioLight will receive NIS 8.9 million cash immediately and payments of up to $10.8 million if Belkin Vision achieves all its milestones - in other words an amount significantly higher than BioLight's overall value. Prior to the announcement of Belkin Vision's acquisition, Biolight had booked the value of its stake at just NIS 3.6 million.

US marketing approval

Last December, Belkin Vision received FDA marketing approval in the US for its laser-based device for treating glaucoma. The company was founded in 2013 as Belkin Laser to develop a non-contact laser treatment that is more effective and accessible in the treatment of glaucoma. In February 2024 Belkin Vision raised $12.3 million, bringing the total amount raised by the company to $40 million. The company has also received a $17.5 million grant from the EU.

The company was founded by ophthalmologist Prof. Michael Belkin as part of Sheba Medical Center's ARC project, together with CEO Daria Lemann-Blumenthal.

Alcon is expected to promote the use of Belkin Vision's product as a first line treatment for glaucoma. Alcon is a leading international corporation in the field of ophthalmology, and in the field of glaucoma it markets eye care and implants, and now it will also add a laser product. The product has been approved for marketing in Europe and the US, but to date has not been marketed in the US.

Published by Globes, Israel business news - en.globes.co.il - on July 3, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Daria Lemann-Blumenthal credit: Tim Kerr
Daria Lemann-Blumenthal credit: Tim Kerr
Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018